Position in AZN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$375,507,326
+$2,737,667 QoQ
Shares Held
1,980,315
+4.8% QoQ
Ownership
0.128%
of shares outstanding
% of Portfolio
4.25%
of 13F equity value
Holder Rank
#69
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LGT Group Foundation holds $1,204,398,927 across 9 Drug Manufacturers - General names. AZN ranks #2 (31.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
399,659 | $479,363,031 | |
| 2 | AZN |
Astrazeneca PLC
This page
|
1,980,315 | $375,507,326 | |
| 3 | JNJ |
Johnson & Johnson
|
527,334 | $133,927,012 | |
| 4 | ABBV |
AbbVie Inc.
|
441,958 | $111,214,309 | |
| 5 | PFE |
Pfizer Inc
|
2,367,455 | $57,008,312 | |
| 6 | MRK |
Merck & Co., Inc.
|
205,618 | $26,421,912 | |
| 7 | AMGN |
Amgen Inc
|
53,947 | $19,535,286 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
19,269 | $1,110,279 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $375,507,326 | 1,980,315 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $372,769,659 | 1,890,121 | Shares | Defined | 2026-04-28 | |
| No filing history on record for this holder in this stock. | ||||||